Difference between revisions of "MEDICATION-AMIODARONE"
From NeuroRehab.wiki
(Imported from text file) |
(Imported from text file) |
||
| Line 1: | Line 1: | ||
1. Class III anti-arrhythmic agent that prolongs conduction through atrial, nodal, ventricular tissue.<div>2. Reduces the frequency of stimuli reaching the ventricle without causing negative inotropic effects, increases coronary blood flow.</div><div>3. Indications: AF, atrial flutter, SVT, conscious VT, VT/VF refractory to defibrillation, prophylaxis for VT/VF.</div><div>4. SE: hypotension, bradycardia, heart block, thrombophlebitis. Common long-term SE: hypothyroidism.</div><div><br></div><div>DOSAGE</div><div>5. Give 300-450 mg every third DC shock.</div> | <div>1. Class III anti-arrhythmic agent that prolongs conduction through atrial, nodal, ventricular tissue.<div>2. Reduces the frequency of stimuli reaching the ventricle without causing negative inotropic effects, increases coronary blood flow.</div><div>3. Indications: AF, atrial flutter, SVT, conscious VT, VT/VF refractory to defibrillation, prophylaxis for VT/VF.</div><div>4. SE: hypotension, bradycardia, heart block, thrombophlebitis. Common long-term SE: hypothyroidism.</div><div><br></div><div>DOSAGE</div><div>5. Give 300-450 mg every third DC shock.</div> | ||
[[Category:Medication]] | [[Category:Medication]] | ||
[[Category:Advanced Life Support]] | [[Category:Advanced Life Support]] | ||
Revision as of 11:50, 15 December 2022
1. Class III anti-arrhythmic agent that prolongs conduction through atrial, nodal, ventricular tissue.
2. Reduces the frequency of stimuli reaching the ventricle without causing negative inotropic effects, increases coronary blood flow.
3. Indications: AF, atrial flutter, SVT, conscious VT, VT/VF refractory to defibrillation, prophylaxis for VT/VF.
4. SE: hypotension, bradycardia, heart block, thrombophlebitis. Common long-term SE: hypothyroidism.
DOSAGE
5. Give 300-450 mg every third DC shock.
